Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Higashitani

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Chemotherapy|May 1, 1997
Superior effect of tazobactam/piperacillin compared to piperacillin on beta-lactamase-producing Pseudomonas aeruginosaK Nishida, F Higashitani, A Hyodo
Physiology & Behavior|January 1, 1986
Sex differences in appetitive learning of miceN Mishima, F Higashitani, K Teraoka, et al.
The Journal of Antibiotics|September 1, 1995
Effects of tazobactam on the frequency of the emergence of resistant strains from Enterobacter cloacae, Citrobacter freundii, and Proteus vulgaris (beta-lactamase derepressed mutants)F Higashitani, K Nishida, A Hyodo, et al.
The Journal of Antibiotics|December 1, 1995
Characterization of a new plasmid-mediated extended-spectrum beta-lactamase from Serratia marcescensC Kunugita, F Higashitani, A Hyodo, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 1, 1997
[Development of beta-lactamase inhibitors]A Hyodo, F Higashitani, K Nishida, et al.
The Journal of Antimicrobial Chemotherapy|April 1, 1990
Inhibition of beta-lactamases by tazobactam and in-vitro antibacterial activity of tazobactam combined with piperacillinF Higashitani, A Hyodo, N Ishida, et al.
Antimicrobial Agents and Chemotherapy|August 3, 1999
In vitro and in vivo activities of Syn2190, a novel beta-lactamase inhibitorK Nishida, C Kunugita, T Uji, et al.
Antimicrobial Agents and Chemotherapy|August 15, 2001
In vitro and in vivo activities of syn2836, syn2869, syn2903, and syn2921: new series of triazole antifungal agentsS M Salama, H Atwal, A Gandhi, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Chemotherapy|May 1, 1997
Superior effect of tazobactam/piperacillin compared to piperacillin on beta-lactamase-producing Pseudomonas aeruginosaK Nishida, F Higashitani, A Hyodo
Physiology & Behavior|January 1, 1986
Sex differences in appetitive learning of miceN Mishima, F Higashitani, K Teraoka, et al.
The Journal of Antibiotics|September 1, 1995
Effects of tazobactam on the frequency of the emergence of resistant strains from Enterobacter cloacae, Citrobacter freundii, and Proteus vulgaris (beta-lactamase derepressed mutants)F Higashitani, K Nishida, A Hyodo, et al.
The Journal of Antibiotics|December 1, 1995
Characterization of a new plasmid-mediated extended-spectrum beta-lactamase from Serratia marcescensC Kunugita, F Higashitani, A Hyodo, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 1, 1997
[Development of beta-lactamase inhibitors]A Hyodo, F Higashitani, K Nishida, et al.
The Journal of Antimicrobial Chemotherapy|April 1, 1990
Inhibition of beta-lactamases by tazobactam and in-vitro antibacterial activity of tazobactam combined with piperacillinF Higashitani, A Hyodo, N Ishida, et al.
Antimicrobial Agents and Chemotherapy|August 3, 1999
In vitro and in vivo activities of Syn2190, a novel beta-lactamase inhibitorK Nishida, C Kunugita, T Uji, et al.
Antimicrobial Agents and Chemotherapy|August 15, 2001
In vitro and in vivo activities of syn2836, syn2869, syn2903, and syn2921: new series of triazole antifungal agentsS M Salama, H Atwal, A Gandhi, et al.
Pageof 1